Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.

Source:http://linkedlifedata.com/resource/pubmed/id/17950521

Download in:

View as

General Info

PMID
17950521